webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-N-amido-PEG5-acetic acid

  CAS No.: 635287-26-2   Cat No.: BADC-01142   Purity: ≥95% 4.5  

Fmoc-N-amido-PEG5-acetic acid offers a longer PEG5 spacer with an Fmoc group, supporting advanced ADC linker synthesis. Its enhanced hydrophilicity and protecting group allow precise stepwise conjugation in antibody-drug conjugate production.

Fmoc-N-amido-PEG5-acetic acid

Structure of 635287-26-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C27H35NO9
Molecular Weight
517.57
Shipping
Room temperature
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-NH-PEG5-CH2COOH; Fmoc-NH-5(ethylene glycol)-acetic acid; Fmoc-PEG5-acetic acid; 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azahenicosan-21-oic acid; 17-[(9-Fluorenylmethoxycarbonyl)amino]-3,6,9,12,15-pentaoxaheptadecanoic acid; 5,8,11,14,17-Pentaoxa-2-azanonadecanedioic acid 1-(9H-fluoren-9-ylmethyl) ester; 2,7,10,13,16,19-Hexaoxa-4-azaheneicosan-21-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-
IUPAC Name
2-[2-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCCOCCOCC(=O)O
InChI
InChI=1S/C27H35NO9/c29-26(30)20-36-18-17-35-16-15-34-14-13-33-12-11-32-10-9-28-27(31)37-19-25-23-7-3-1-5-21(23)22-6-2-4-8-24(22)25/h1-8,25H,9-20H2,(H,28,31)(H,29,30)
InChIKey
LNIFRTLAPAPKAG-UHFFFAOYSA-N
Density
1.224±0.06 g/cm3 (Predicted)
Solubility
Soluble in DMSO (10 mm)
PSA
121.78000
Appearance
Pale Yellow or Colorless Oily Liquid
Shipping
Room temperature
Storage
Store at 2-8°C
Boiling Point
704.3±60.0°C (Predicted)

Fmoc-N-amido-PEG5-acetic acid is a versatile compound widely used in peptide and bioconjugation chemistry. The Fmoc (9-fluorenylmethyloxycarbonyl) group protects the amino terminus, facilitating stepwise synthesis of peptides in solid-phase peptide synthesis (SPPS). This protection ensures controlled addition of amino acid residues and other functional moieties, making it a critical building block in the development of functionalized peptides and complex biomolecules.

A key feature of Fmoc-N-amido-PEG5-acetic acid is the incorporation of a polyethylene glycol (PEG) chain with five ethylene glycol units. The PEG5 moiety enhances the solubility and flexibility of the compound, which is particularly advantageous in bioconjugation. The PEG chain acts as a hydrophilic spacer, reducing steric hindrance and improving the bioavailability, stability, and pharmacokinetics of peptide-based drugs or conjugates. This functionality makes the compound essential for the synthesis of biocompatible and long-circulating therapeutic agents.

Fmoc-N-amido-PEG5-acetic acid is extensively used in the development of peptide-drug conjugates (PDCs) and antibody-drug conjugates (ADCs). The PEG5 spacer facilitates the precise attachment of cytotoxic agents, targeting ligands, or imaging probes to peptides or antibodies while maintaining their bioactivity. This tailored conjugation improves drug targeting to diseased tissues, such as tumors, while minimizing off-target effects, making it crucial for advanced drug delivery systems.

Another significant application of Fmoc-N-amido-PEG5-acetic acid is in the design of self-assembling peptides and hydrogels. The PEG chain enhances the hydrophilic properties of peptides, promoting the formation of stable nanostructures such as micelles, vesicles, or hydrogels. These structures have broad applications in drug delivery, regenerative medicine, and tissue engineering. The flexibility of the PEG5 linker allows researchers to fine-tune the physical and chemical properties of the resulting materials, optimizing their performance for specific biomedical applications.

Additionally, Fmoc-N-amido-PEG5-acetic acid is used in surface modification and biomaterials engineering. It enables the attachment of peptides or other bioactive molecules to surfaces, such as nanoparticles, hydrogels, or biosensors, to improve biocompatibility and functionalization. This capability is highly valuable in creating targeted delivery systems, diagnostic tools, and biosensing devices, ensuring precise interactions with biological environments.

1. Acidity characterization of heterogeneous catalysts by solid-state NMR spectroscopy using probe molecules
Anmin Zheng, Shang-Bin Liu, Feng Deng Solid State Nucl Magn Reson. 2013 Oct-Nov;55-56:12-27. doi: 10.1016/j.ssnmr.2013.09.001. Epub 2013 Sep 20.
Characterization of the surface acidic properties of solid acid catalysts is a key issue in heterogeneous catalysis. Important acid features of solid acids, such as their type (Brønsted vs. Lewis acid), distribution and accessibility (internal vs. external sites), concentration (amount), and strength of acid sites are crucial factors dictating their reactivity and selectivity. This short review provides information on different solid-state NMR techniques used for acidity characterization of solid acid catalysts. In particular, different approaches using probe molecules containing a specific nucleus of interest, such as pyridine-d5, 2-(13)C-acetone, trimethylphosphine, and trimethylphosphine oxide, are compared. Incorporation of valuable information (such as the adsorption structure, deprotonation energy, and NMR parameters) from density functional theory (DFT) calculations can yield explicit correlations between the chemical shift of adsorbed probe molecules and the intrinsic acid strength of solid acids. Methods that combine experimental NMR data with DFT calculations can therefore provide both qualitative and quantitative information on acid sites.
2. The Stephan Curve revisited
William H Bowen Odontology. 2013 Jan;101(1):2-8. doi: 10.1007/s10266-012-0092-z. Epub 2012 Dec 6.
The Stephan Curve has played a dominant role in caries research over the past several decades. What is so remarkable about the Stephan Curve is the plethora of interactions it illustrates and yet acid production remains the dominant focus. Using sophisticated technology, it is possible to measure pH changes in plaque; however, these observations may carry a false sense of accuracy. Recent observations have shown that there may be multiple pH values within the plaque matrix, thus emphasizing the importance of the milieu within which acid is formed. Although acid production is indeed the immediate proximate cause of tooth dissolution, the influence of alkali production within plaque has received relative scant attention. Excessive reliance on Stephan Curve leads to describing foods as "safe" if they do not lower the pH below the so-called "critical pH" at which point it is postulated enamel dissolves. Acid production is just one of many biological processes that occur within plaque when exposed to sugar. Exploration of methods to enhance alkali production could produce rich research dividends.
3. Atroposelective Synthesis of 1,1'-Bipyrroles Bearing a Chiral N-N Axis: Chiral Phosphoric Acid Catalysis with Lewis Acid Induced Enantiodivergence
Yaru Gao, Luo-Yu Wang, Tao Zhang, Bin-Miao Yang, Yu Zhao Angew Chem Int Ed Engl. 2022 Apr 11;61(16):e202200371. doi: 10.1002/anie.202200371. Epub 2022 Feb 24.
We present herein a highly efficient atroposelective synthesis of axially chiral 1,1'-bipyrroles bearing an N-N linkage from simple hydrazine and 1,4-diones. Further product derivatizations led to axially chiral bifunctional compounds with high potential in asymmetric catalysis. For this chrial phosphoric acid (CPA)-catalyzed double Paal-Knorr reaction, an intriguing Fe(OTf)3 -induced enantiodivergence was also observed.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Datopotamab deruxtecan | Seco-Duocamycin GA | Amino-bis-PEG3-BCN | MC-Val-Ala-PBD | Azide-PEG1-Val-Cit-PABC-OH | MC-Val-Ala-SG3199 | Taltobulin | Epirubicin | Methyltetrazine-PEG4-hydrazone-DBCO | m-PEG8-COOH | Fmoc-N-amido-PEG5-acetic acid
Send Inquiry
Verification code
Inquiry Basket